gastroenterology
IBD

Early use of immunomodulators prevents perianal disease in IBD kids

Early use of immunomodulators and biologic agents in paediatric Crohn’s disease reduces the risk of perianal disease by about 60% within two years, a US study shows A retrospective analysis of records for 2214 young people with CD under the age of 24 without perianal disease at baseline found that almost 20% developed perianal fistulising ...

Already a member?

Login to keep reading.


OR
© 2020 the limbic